Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Back of the Napkin - Inspiring Stories from Biotech Pioneers

Laura L. Kiessling: Chemical Biology, Carbohydrates and Women in Science

01 Mar 2024

Description

Laura Kiessling is the Novartis Professor of Chemistry at Massachusetts Institute of Technology (MIT). In this episode of Back of the Napkin, beginning in Laura's art-adorned office at MIT, the conversation explores her journey from a small Wisconsin town to the pinnacles of scientific research and education at MIT.Laura's professional trajectory is a testament to her passion for science — from her top performance in a university chemistry class to her inspired transfer to MIT following a serendipitous spring break encounter with women doing amazing science in Boston. Her curiosity about the unknown and desire to push boundaries in chemistry led her to explore the intricate world of carbohydrates and their profound impact on diseases such as tuberculosis. Laura has advised approximately 100 graduate students and postdoctorates and emphasizes that the essence of scientific progress is distilled not only through individual brilliance but also through the profound impact of community, collaboration, and mentorship. Laura is not only a proponent but a role model for women in science, advocating for equal representation, mentorship, and recognition. Her narrative is punctuated with instances where she challenged the norms and paved the way for others to follow.Links:Lessons in Chemistry Book: https://bit.ly/3wCnTGSPublication - Glycan-costumed virus-like particles promote type 1 anti-tumor immunity: https://bit.ly/49UWxdrLaura's Twitter: https://twitter.com/ChemicalBiology

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
šŸ—³ļø Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.